Results 251 to 260 of about 899,405 (297)

Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells

Nature Immunology, 2020
Faezzah Baharom, Hidehiro Yamane, Charles-Antoine Dutertre   +2 more
exaly  

SAFETY OF INTRAVENOUS IMMUNOGLOBULIN

The Lancet, 1987
W L, Shaw, R R, Stewart
openaire   +2 more sources

Efficacy of combined intravenous immunoglobulins and steroids in children with primary immune thrombocytopenia and persistent bleeding symptoms.

Blood transfusion = Trasfusione del sangue, 2014
E. Parodi, P. Giordano, E. Rivetti, M. Giraudo, G. Ansaldi, M. Davitto, A. Mondino, P. Farruggia, G. Amendola, S. M. Matarese, F. Rossi, G. Russo, U. Ramenghi   +12 more
semanticscholar   +1 more source

Intravenous Immunoglobulin

JAMA, 1990
openaire   +1 more source

Natural Autoantibodies to Fcγ Receptors in Intravenous Immunoglobulins

Journal of Clinical Immunology, 2014
H. Bouhlal, D. Martinvalet, J. Teillaud, C. Fridman, M. Kazatchkine, J. Bayry, S. Lacroix-Desmazes, S. Kaveri   +7 more
semanticscholar   +1 more source

[Intravenous immunoglobulins].

Bulletin de l'Academie nationale de medecine, 2013
openaire   +3 more sources

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Nature Reviews Immunology, 2013
Falk Nimmerjahn
exaly  

Intravenous Immunoglobulin

2015
Francisco Kerdel, Luis Dehesa
openaire   +1 more source

[Intravenous immunoglobulin therapy].

La Revue du praticien, 2005
Intravenous immunoglobulins (IVIg) are therapeutic preparations of normal human IgG that are obtained from pools of healthy blood donors. They can be used at low dose in the substitutive therapy of patients with primary or secondary immune deficiencies, or at high dose as an immunomodulatory agent in a large number of autoimmune and/or systemic ...
openaire   +1 more source

Intravenous fluid therapy in critically ill adults

Nature Reviews Nephrology, 2018
Simon R Finfer, John Myburgh, Rinaldo Bellomo   +2 more
exaly